J&J | JNJ - Debt



J&J reported $52.25B in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
AbbVie USD 69.89B 2.74B Mar/2025
Abbott USD 13.44B 195M Jun/2025
Amgen USD 56.2B 1.18B Jun/2025
AstraZeneca USD 32.84B 1.19B Jun/2025
Baxter International USD 10.31B 2.82B Mar/2025
Bayer EUR 39.39B 1.31B Mar/2025
Becton, Dickinson and Co. USD 19.34B 71M Jun/2025
Biogen USD 6.59B 296.8M Jun/2025
Boston Scientific USD 11.31B 563M Mar/2025
Bristol-Myers Squibb USD 50.93B 1.22B Jun/2025
CONMED USD 881.82M 10.33M Jun/2025
Cooper Companies USD 2.48B 107.1M Jul/2025
Dexcom USD 2.58B 78.4M Jun/2025
Edwards Lifesciences USD 699.4M 101.7M Mar/2025
Eli Lilly USD 39.9B 1.39B Jun/2025
Gilead Sciences USD 24.95B 6M Jun/2025
GlaxoSmithKline GBP 17.35B 1.08B Jun/2025
Globus Medical USD 477K 443.4M Mar/2025
Hologic USD 2.52B 8.5M Jun/2025
Insulet USD 1.4B 295.7M Jun/2025
Integra LifeSciences USD 2.01B 170.48M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 52.25B 15.62B Mar/2025
Medtronic USD 28.52B 1.91B Apr/2025
Merck USD 34.84B 2.27B Mar/2025
Merit Medical Systems USD 820.55M 89.88M Jun/2025
Novartis USD 31.27B 12M Mar/2025
Pfizer USD 60.93B 1.18B Jun/2025
Regeneron Pharmaceuticals USD 2.71B 300K Jun/2025
Roche Holding CHF 34.44B 5.23B Jun/2024
Sanofi 22.28B 1.24B Jun/2025
Stryker USD 16.58B 201M Jun/2025
Tandem Diabetes Care USD 449.01M 94.67M Jun/2025
Teva Pharmaceutical Industries USD 17.52B 872M Jun/2025
Vertex Pharmaceuticals USD 1.53B 121.7M Jun/2025
Zimmer Biomet Holdings USD 7.57B 396.2M Jun/2025
Zoetis USD 6.79B 214M Jun/2025